PTSD
Brain imaging biomarker could predict how psychiatric disorder patients respond to treatment
October 21, 2020Research and Development MDMA, PTSD
A recent study has indicated that a newly identified brain imaging biomarker could help match patients with psychiatric disorders with …
First clinical trial for MDMA and LSD combination set to go ahead
August 28, 2020Medical Communications LSD, MDMA, PTSD
Researchers are set to investigate a combined dose of LSD and MDMA to treat patients undergoing psychotherapy. The Phase 1 …
Study finds that MDMA has long-term benefits for treating PTSD
June 11, 2020Business Services MDMA, PTSD
PTSD patients being treated with MDMA experience numerous beneficial effects that hold strong for well after a year after completing …
New study casts doubt on effectiveness of psychotherapy treatments for military-related PTSD
February 4, 2020Manufacturing and Production PTSD, PTSD Iraq, PTSD Therapy, PTSD WAR, PTSD military
A recent review of clinical trials shows that first-line psychotherapies are limited in how effectively they treat veterans with PTSD.
FDA puts MDMA therapy for PTSD on its Expanded Access program
January 24, 2020Medical Communications Expanded Access, MAPS, MDMA, PTSD, pharmaceuticals, psychedelics, war
The FDA has made MDMA treatment for PTSD more accessible by putting it on the Expanded Access program. 10 sites …
Patients to recieve MDMA-assisted psychotherapy on ‘compassionate’ grounds in Israel
February 28, 2019Research and Development MDMA, PTSD, drugs, mental health, psychedelics
The Israeli Health Ministry has approved the compassionate use of MDMA-assisted psychotherapy for 50 patients with post-traumatic stress disorder (PTSD). …
76% of patients no longer experience PTSD a year after MDMA-assisted psychotherapy
November 6, 2018Manufacturing and Production, Research and Development MDMA, PTSD, mental health, psychotherapy, research
Promising phase II results suggest that MDMA-assisted psychotherapy may be an “innovative, efficacious treatment for posttraumatic stress disorder,” according to …
Tonix plunges 68% after PTSD drug failure
July 30, 2018Research and Development, Sales and Marketing PTSD, Tonmya, pharma, tonix
Tonix Pharmaceuticals has announced that it has terminated its Phase 3 study of Tonmya (cyclobenzaprine HCl sublingual tablets) in military-related …
Recreational drug MDMA proves efficacy in reducing PTSD symptoms, new study finds
May 3, 2018Research and Development MDMA, PTSD, pharma
Promising new findings have been revealed in the efficacy of MDMA in treating post-traumatic stress disorder (PTSD).
FDA fast-tracks recreational drug MDMA for treatment of PTSD
August 30, 2017Research and Development, Sales and Marketing FDA, MDMA, PTSD, life sciences, pharma, pharmaceuticals
In another leap forward for the promising treatment, the FDA has announced that it has granted Breakthrough Therapy Designation to …
Common antibiotic shows promise as novel PTSD treatment
April 5, 2017Research and Development PTSD, UCL, antibiotic, doxycycline
Research coming out of University College London (UCL) and the University of Zurich has indicated that common antibiotic doxycycline could …
MDMA trials get FDA backing for PTSD treatment
November 30, 2016Research and Development FDA, MDMA, PTSD
The FDA have given the go-ahead to Phase 3 clinical trials investigating the efficacy of MDMA (Methylenedioxymethamphetamine) for treating post-traumatic …
Tonix tanks after Phase III failure
September 7, 2016Research and Development PTSD, fibromylagia, phase III failure, tonix, tonix pharmaceuticals
New York-based Tonix Pharmaceuticals has suffered an almost 60% fall in their share price, after the announcement that its fibromyalgia …
Digital Pharma – Online patient recruitment drive for GSK’s anxiety drug
January 26, 2010Research and Development GlaxoSmithKline, PTSD, digital research, orvepitant, patient recruitment
GlaxoSmithKline is readying to move its post-traumatics stress disorder candidate orvepitant into phase II trials, a move being supported by …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
